Flying high on huge demand, AppLovin stock resets to target a fresh breakout on forecasts of 315% earnings growth.

A four year-long research study has found that particles secreted by an intestinal worm may assist in treating inflammatory ...

Construction materials supplier CRH cleared a buy point Thursday after announcing plans to unload its stake in SigmaRoc.

Mozart Therapeutics, the leading developer of CD8 Treg network modulators in autoimmune disease, announces the presentation ...

A Relative Strength Rating upgrade for Gold Field ADR shows improving technical performance. Will it continue?

Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a ...

Patients with ankylosing spondylitis and IBD exhibit distinct clinical and radiographic features, compared against those without comorbid IBD.

U.S. Foods is Wednesday's IBD Stock Of The Day as the food distributor looks to break out above a buy point before closing ...

People living with inflammatory bowel disease (IBD) have new hope, with clinical trials beginning for a breakthrough treatment for one of the most ...

Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...

The use of fecal microbiota, live-jslm (RBL; REBYOTA®) in the prevention of recurrent Clostridioides difficile infection ...

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...